These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18519038)

  • 1. Calcium-induced tripartite binding of intrinsically disordered calpastatin to its cognate enzyme, calpain.
    Kiss R; Bozoky Z; Kovács D; Róna G; Friedrich P; Dvortsák P; Weisemann R; Tompa P; Perczel A
    FEBS Lett; 2008 Jun; 582(15):2149-54. PubMed ID: 18519038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local structural preferences of calpastatin, the intrinsically unstructured protein inhibitor of calpain.
    Kiss R; Kovács D; Tompa P; Perczel A
    Biochemistry; 2008 Jul; 47(26):6936-45. PubMed ID: 18537264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin.
    Hanna RA; Campbell RL; Davies PL
    Nature; 2008 Nov; 456(7220):409-12. PubMed ID: 19020623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding-induced folding transitions in calpastatin subdomains A and C.
    Mucsi Z; Hudecz F; Hollósi M; Tompa P; Friedrich P
    Protein Sci; 2003 Oct; 12(10):2327-36. PubMed ID: 14500891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folding transitions in calpain activator peptides studied by solution NMR spectroscopy.
    Toke O; Bánóczi Z; Tárkányi G; Friedrich P; Hudecz F
    J Pept Sci; 2009 Jun; 15(6):404-10. PubMed ID: 19378261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calpastatin has two distinct sites for interaction with calpain--effect of calpastatin fragments on the binding of calpain to membranes.
    Kawasaki H; Emori Y; Suzuki K
    Arch Biochem Biophys; 1993 Sep; 305(2):467-72. PubMed ID: 8373185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary contact sites in intrinsically unstructured proteins: the case of calpastatin and microtubule-associated protein 2.
    Csizmók V; Bokor M; Bánki P; Klement E; Medzihradszky KF; Friedrich P; Tompa K; Tompa P
    Biochemistry; 2005 Mar; 44(10):3955-64. PubMed ID: 15751971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac high molecular weight calmodulin-binding protein is homologous to calpastatin I and calpastatin II.
    Singh N; Shrivastav A; Olson D; Lakshmikuttyamma A; Ross A; Parr T; Bardsley RG; Sharma RK
    Biochem Biophys Res Commun; 2008 Aug; 373(3):387-91. PubMed ID: 18572013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting the active conformation of calpain with calpastatin-based reagents.
    Croall DE; Vanhooser LM; Cashon RE
    Biochim Biophys Acta; 2008 Nov; 1784(11):1676-86. PubMed ID: 18793761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preference of calcium-dependent interactions between calmodulin-like domains of calpain and calpastatin subdomains.
    Takano E; Ma H; Yang HQ; Maki M; Hatanaka M
    FEBS Lett; 1995 Mar; 362(1):93-7. PubMed ID: 7698360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of Endogenous Calpastatin.
    De Tullio R; Averna M
    Methods Mol Biol; 2019; 1915():187-194. PubMed ID: 30617804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between catalytically inactive calpain and calpastatin. Evidence for its occurrence in stimulated cells.
    Averna M; Stifanese R; De Tullio R; Defranchi E; Salamino F; Melloni E; Pontremoli S
    FEBS J; 2006 Apr; 273(8):1660-8. PubMed ID: 16623703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirement of different subdomains of calpastatin for calpain inhibition and for binding to calmodulin-like domains.
    Ma H; Yang HQ; Takano E; Lee WJ; Hatanaka M; Maki M
    J Biochem; 1993 May; 113(5):591-9. PubMed ID: 8340353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Calpain-calpastatin system in erythrocytes of children with chronic renal failure].
    Polak-Jonkisz D; Purzyc L; Zwolińska D; Musiał K
    Przegl Lek; 2006; 63 Suppl 3():156-8. PubMed ID: 16898518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affinity purification of human m-calpain through an intrinsically disordered inhibitor, calpastatin.
    Nguyen HH; Varadi M; Tompa P; Pauwels K
    PLoS One; 2017; 12(3):e0174125. PubMed ID: 28319173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of calpastatin with calpain: a review.
    Wendt A; Thompson VF; Goll DE
    Biol Chem; 2004 Jun; 385(6):465-72. PubMed ID: 15255177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cold stability of intrinsically disordered proteins.
    Tantos A; Friedrich P; Tompa P
    FEBS Lett; 2009 Jan; 583(2):465-9. PubMed ID: 19121309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and immunolocalization of the calpain-calpastatin system in the human oocyte.
    Ben-Aharon I; Ben-Yosef D; Amit A; Shalgi R
    Fertil Steril; 2005 Jun; 83(6):1807-13. PubMed ID: 15950654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calpastatin simultaneously binds four calpains with different kinetic constants.
    Hanna RA; Garcia-Diaz BE; Davies PL
    FEBS Lett; 2007 Jun; 581(16):2894-8. PubMed ID: 17543955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A structural model for the inhibition of calpain by calpastatin: crystal structures of the native domain VI of calpain and its complexes with calpastatin peptide and a small molecule inhibitor.
    Todd B; Moore D; Deivanayagam CC; Lin GD; Chattopadhyay D; Maki M; Wang KK; Narayana SV
    J Mol Biol; 2003 Apr; 328(1):131-46. PubMed ID: 12684003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.